judge denies 6 of the 14 motions....
docket No Made Motion Action Motion
473 Roche DENIED
Summary Judgment That Claim 10 of the '933 Patent is Invalid on the Ground of Failure to Comply
with Claim Differentiation Under Section 112
478 Roche DENIED
Summary Judgment of Non-Infringement of Claim 1 of Patent No. 5,955,422 and Claims 9 and 12 of
Patent No. 5,547,933 ,
498 Amgen Summary Judgment of No Obviousness-Type Double Patenting
509 Amgen Summary Judgment of Infringement of '422 Claim 1, '933 Claim 3, and '698 Claim 6 ,
490 Roche DENIED
Summary Judgment That The Claims Of Patents-In-Suit Are Invalid For Double Patenting Over
Amgen 016 Patent
518 Amgen Summary Judgment on Roche's Antitrust and State Law Conterclaims
482 Roche DENIED Summary Judgment That Claim 1 of the '422 Patent is Invalid Under 35 U.S.C. Sec. 112
505 Roche DENIED
Summary Judgment That the Asserted Claims of the '933 Patent are Invalid for Indefiniteness and
Lack of Written Description
531 Amgen Summary Judgment That Dr. Lin's Asserted Claims are Definite, Adequately Described and Enabled
539 Roche
Summary Judgment That Claim 7 of Patent No. 5,756,349 Is Invalid Under 35 U.S.C. Sec. 112 and
Is Not Infringed
544 Amgen DENIED Summary Judgment of No Inequitable Conduct
620 Roche
Summary Judgment that Amgen is Estopped from Asserting Infringment Under the Doctrine of
Equivalents of the Asserted Claims of the '933 and '422 Patents ,
624 Roche
Summary Judgment that Amgen is Estopped from Asserting Infringement Under the Doctrine of
Equivalents of the Asserted Claims of the '698 and '868 Patents
614 Roche
Summary Judgment That Claim 1 Of U.S. Patent No. 5,995,422 Is Invalid For Indefiniteness And
Lack Of Written Description |
